Lee, J., Lee, J. Y., Kim, D. K., Yoon, H. I., Jeong, I., Heo, E. Y., Park, Y. S., Jo, Y. S., Lee, J. H., Park, S. S., Park, J. S., Kim, J., Lee, S., Joh, J., Lee, C., Lee, J., Choi, S. M., Park, J., Lee, S. H., Cho, Y., Lee, Y. J., Kim, S. J., Kwak, N., Hwang, Y. R., Kim, H., Ki, J., Lim, J. N., Choi, H. S., Lee, M., Song, T., Kim, H. S., Han, J., Ahn, H., Hahn, S., & Yim, J. (2019). substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial. Lancet infectious diseases, 19(1), 46–55. http://access.bl.uk/ark:/81055/vdc_100074896937.0x00000e